Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 115, Issue 1, 2013, Pages 95-103

  Kong, Christina S ^a   Cao, Hongbin ^b   Kwok, Shirley ^a   Nguyen, Catherine M ^a   Jordan, Richard C ^c   Beaudry, Veronica G ^b   Attardi, Laura D ^b   Le, Quynh Thu ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; MEMBRANE PROTEIN; PERP PROTEIN, HUMAN; PROTEIN P53; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CELL TRANSFORMATION; CHI SQUARE DISTRIBUTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CELL TRANSFORMATION, NEOPLASTIC; CHI-SQUARE DISTRIBUTION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84870887715     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2012.10.017     Document Type: Article

References (28)

1. Y.J. Chen, J.T. Chang, L. Lee, H.M. Wang, C.T. Liao, C.C. Chiu DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis Oncogene 26 2007 467 476
2. S. Papagerakis, A.H. Shabana, B.H. Pollock, P. Papagerakis, J. Depondt, A. Berdal Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer Hum Pathol 40 2009 1320 1329
3. J. Depondt, A.H. Shabana, S. Florescu-Zorila, P. Gehanno, N. Forest Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis Eur J Oral Sci 107 1999 183 193
4. L.D. Attardi, E.E. Reczek, C. Cosmas, E.G. Demicco, M.E. McCurrach, S.W. Lowe, T. Jacks PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family Genes Dev 14 2000 704 718
5. V.G. Beaudry, D. Jiang, R.L. Dusek, E.J. Park, S. Knezevich, K. Ridd Loss of the p53/p63 regulated desmosomal protein perp promotes tumorigenesis PLoS Genet 6 2010 e1001168
6. R.L. Dusek, J.L. Bascom, H. Vogel, S. Baron, A.D. Borowsky, M.J. Bissell Deficiency of the p53/p63 target perp alters mammary gland homeostasis and promotes cancer, breast Cancer Res 14 2012 R65
7. R.A. Ihrie, M.R. Marques, B.T. Nguyen, J.S. Horner, C. Papazoglu, R.T. Bronson PERP is a p63-regulated gene essential for epithelial integrity Cell 120 2005 843 856
8. M.R. Marques, J.S. Horner, R.A. Ihrie, R.T. Bronson, L.D. Attardi Mice lacking the p53/p63 target gene Perp are resistant to papilloma development Cancer Res 65 2005 6551 6556
9. A. Forastiere, W. Koch, A. Trotti, D. Sidransky Head and neck cancer N Engl J Med 345 2001 1890 1900
10. A. Cardesa, N. Gale, A. Nadal, N. Zidar Squamous cell carcinoma E.L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky, Pathology and Genetics of Head and Neck Tumours (IARC WHO Classification of Tumours) 2005 IARC Lyon 119
11. D.G.S. MacDonald Structural indicators of the high risk lesion N.W. Johnson, Risk Markers for Oral Diseases: Volume 1, Dental Caries: Markers of High and Low Risk Groups and Individuals 1991 Cambridge University Press Cambridge, UK 165 187
12. D.J. Brothwell, D.W. Lewis, G. Bradley, I. Leong, R.C. Jordan, D. Mock, J.L. Leake Observer agreement in the grading of oral epithelial dysplasia Community Dent Oral Epidemiol 31 2003 300 305
13. C.L. Liu, W. Prapong, Y. Natkunam, A. Alizadeh, K. Montgomery, C.B. Gilks, M. van de Rijn Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays Am J Pathol 161 2002 1557 1565
14. S.A.S. Glanz Primer of applied regression analysis of variance 1990 McGraw-Hill New York
15. D.R. Cox Regression models and life tables J R Stat Soc 34 1972 187 229
16. P. Roepman, F.C. Holstege Tumor profiling turmoil Cell Cycle 4 2005 659 660
17. S. Colella, K.L. Richards, L.L. Bachinski, K.A. Baggerly, S. Tsavachidis, J.C. Lang Molecular signatures of metastasis in head and neck cancer Head Neck 30 2008 1273 1283
18. P. Roepman, L.F. Wessels, N. Kettelarij, P. Kemmeren, A.J. Miles, P. Lijnzaad An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas Nat Genet 37 2005 182 186
19. R. Luthra, T.T. Wu, M.G. Luthra, J. Izzo, E. Lopez-Alvarez, L. Zhang Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation J Clin Oncol 24 2006 259 267
20. N. Tanaka, T. Odajima, K. Ogi, T. Ikeda, M. Satoh Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma Br J Cancer 89 2003 557 563
21. G.F. Huber, L. Züllig, A. Soltermann, M. Roessle, N. Graf, S.K. Haerle Down regulation of E-cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx BMC Cancer 11 2011 211 218
22. V. Chow, A.P. Yuen, K.Y. Lam, G.S. Tsao, W.K. Ho, W.I. Wei A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma J Cancer Res Clin Oncol 127 2001 59 63
23. M. Diniz-Freitas, T. García-Caballero, J. Antúnez- López, J.M. Gándara-Rey, A. García-García Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma Oral Oncol 42 2006 190 200
24. L.K. Liu, X.Y. Jiang, X.X. Zhou, D.M. Wang, X.L. Song, H.B. Jiang Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome Mod Pathol 23 2010 213 224
25. R. Herrero, X. Castellsagué, M. Pawlita, J. Lissowska, F. Kee, P. Balaram Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study J Natl Cancer Inst 95 2003 1772 1783
26. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, L. Wu Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
27. H. Cao, A. Banh, S. Kwok, X. Shi, S. Wu, T. Krakow Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients Int J Radiat Oncol Biol Phys 82 2012 e351 e358
28. J.E. Lubek, L. Clayman An update on squamous carcinoma of the oral cavity, oropharynx, and maxillary sinus Oral Maxillofac Surg Clin North Am 24 2012 307 316.